retatrutide triple agonist gip glp-1 glucagon mechanism Schematic illustration of monoagonists, dual agonists and How Does Retatrutide Work? Triple – Retatrutide 10mg Triple Agonist |

BEACON CRC (binimetinib [BINI], encorafenib [ENCO], and cetuximab [CTX] combined to treat BRAF-mutant metastatic colorectal cancer [mCRC]): A multicenter, randomized, open-label, three-arm phase III study of ENCO plus CTX plus or minus BINI vs irinotecan (IRI)/CTX or infusional 5-fluorouracil/folinic acid/IRI (FOLFIRI)/CTX with a safety lead-in of ENCO + BINI + CTX in patients (Pts) with BRAFV600E mCRC

The same research showed an 18% reduction in calorie intake at subsequent meals

Bregman employs minimally invasive and minimal incision surgical techniques that reduce tissue disruption, minimize scarring, and support faster recovery

But sustainability depends on acquired skills: meal planning, trigger management, improved sleep quality, sufficient movement, hydration

Given the importance of identifying new therapies for BED and the promising outcomes associated with GLP-1 receptor agonists, this article systematically reviews the effects of these drugs on BED, with a specific focus on their impact on anthropometric variables